EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines-Reference-Cited by-同舟云学术

EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines

Published:2021-06 Issue:6 Volume:76 Page:1629-1639
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Sokolowska Milena¹^ORCID,Eiwegger Thomas²³⁴^ORCID,Ollert Markus⁵⁶,Torres Maria J.⁷^ORCID,Barber Domingo⁸^ORCID,Del Giacco Stefano⁹^ORCID,Jutel Marek¹⁰,Nadeau Kari C.¹¹¹²¹³^ORCID,Palomares Oscar¹⁴^ORCID,Rabin Ronald L.¹⁵,Riggioni Carmen¹⁶¹⁷^ORCID,Vieths Stefan¹⁸,Agache Ioana¹⁹^ORCID,Shamji Mohamed H.²⁰^ORCID

Affiliation:

1. Swiss Institute of Allergy and Asthma Research (SIAF University of Zurich Zurich Switzerland

2. Division of Immunology and Allergy Food Allergy and Anaphylaxis ProgramThe Hospital for Sick Children Toronto ON Canada

3. Translational Medicine Program, Research InstituteThe Hospital for Sick Children Toronto ON Canada

4. Department of Immunology University of Toronto Toronto ON Canada

5. Department of Infection and Immunity Luxembourg Institute of Health Esch‐sur‐Alzette Luxembourg

6. Department of Dermatology and Allergy Center Odense Research Center for AnaphylaxisOdense University HospitalUniversity of Southern Denmark Odense Denmark

7. AllergyClinical UnitHospital Regional Universitario de Málaga‐UMA‐ARADyAL Málaga Spain

8. Departamento de Ciencias Médicas Básicas Facultad de Medicina Instituto de Medicina Molecular Aplicada (IMMAUniversidad San Pablo‐CEUCEU Universities Madrid España

9. Department of Medical Sciences and Public Health University of Cagliari Cagliari Italy

10. Department of Clinical Immunology Wrocław Medical University Wrocław Poland

11. Sean N. Parker Center for Allergy and Asthma Research at Stanford University Stanford University Stanford CA USA

12. Department of Medicine Division of Pulmonary and Critical Care Medicine Stanford University Stanford CA USA

13. Department of Medicine Division of Allergy, Immunology and Rheumatology Stanford University Stanford CA USA

14. Department of Biochemistry and Molecular Biology Chemistry School Complutense University of Madrid Madrid Spain

15. Office of Vaccines Research and Review Center for Biologics Evaluation and Research US Food and Drug Administration Silver Spring MD USA

16. Allergy and Clinical Immunology Department of Paediatrics Yong Loo Lin School of MedicineNational University of Singapore Singapore Singapore

17. Institut de Recerca Sant Joan de Déu Barcelona Spain

18. Paul‐Ehrlich‐Institut Paul‐Ehrlich‐Str. 51‐59 Langen63225Germany

19. Transylvania University Brasov Romania

20. Immunomodulation and Tolerance Group, Allergy and Clinical Immunology Inflammation, Repair and DevelopmentNational Heart and Lung InstituteImperial College London. Asthma UK Centre in Allergic Mechanisms of Asthma London UK

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.14739

Reference39 articles.

1. Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)

2. SARS‐CoV‐2 candidate vaccines ‐ composition, mechanisms of action and stages of clinical development

3. European Medical Agency.EMA/660602/2020; EMEA/H/C/005735; 21.12.2020.https://www.ema.europa.eu/en/news/ema‐recommends‐first‐covid‐19‐vaccine‐authorisation‐euAccessed December 30 2020.

4. Medicines and Healthcare products Regulatory Agency (MHRA).Regulatory approval of COVID‐19 Vaccine AstraZeneca.https://www.gov.uk/government/publications/regulatory‐approval‐of‐covid‐19‐vaccine‐astrazenecaAccessed December 30 2020.

5. EAACI Research and Outreach Committee: Improving standards and facilitating global collaboration through a Research Excellence Network

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacovigilance in Brazil: The Government Monitoring of Adverse Events Reported from COVID-19 Vaccine—A Narrative Review;Healthcare;2024-02-01

2. Four years after the beginning of COVID‐19 pandemic and the publication of the first case series;Allergy;2024-01-25

3. Preparing the Allergist/Immunologist for the Next Pandemic;The Journal of Allergy and Clinical Immunology: In Practice;2023-11

4. Basophil activation tests with cryopreserved mRNA-based COVID-19 vaccines;Allergology International;2023-10

5. Understanding factors affecting Chinese medical staff’s fear of receiving the fourth dose of COVID-19 vaccine: A cross-sectional study in Taizhou;Human Vaccines & Immunotherapeutics;2023-08